Meta-analysis of neutropenia or leukopenia as a prognostic factor in patients with malignant disease undergoing chemotherapy.
about
The Risk of Neutropenia and Leukopenia in Advanced Non-Small Cell Lung Cancer Patients Treated With Erlotinib: A Prisma-Compliant Systematic Review and Meta-AnalysisThe Relationship between Common Genetic Markers of Breast Cancer Risk and Chemotherapy-Induced Toxicity: A Case-Control StudyGALNT14 genotype, α-fetoprotein and therapeutic side effects predict post-chemotherapy survival in patients with advanced hepatocellular carcinoma.Carboplatin-paclitaxel-induced leukopenia and neuropathy predict progression-free survival in recurrent ovarian cancer.Impact of body mass index on incidence of febrile neutropenia and treatment-related mortality in United States veterans with diffuse large B-cell lymphoma receiving rituximab, cyclophosphamide, doxorubicin, vincristine, prednisone.A nested cohort study of 6,248 early breast cancer patients treated in neoadjuvant and adjuvant chemotherapy trials investigating the prognostic value of chemotherapy-related toxicities.Comparative analysis of carboplatin and paclitaxel combination chemotherapy schedules in previously untreated patients with advanced non-small cell lung cancer.Randomised phase II study comparing dose-escalated weekly paclitaxel vs standard-dose weekly paclitaxel for patients with previously treated advanced gastric cancer.Toxic effect of chemotherapy dosing using actual body weight in obese versus normal-weight patients: a systematic review and meta-analysis.The circadian timing system in clinical oncology.Adherence, Dosing, and Managing Toxicities With Trifluridine/Tipiracil (TAS-102).Cancer cells induce metastasis-supporting neutrophil extracellular DNA traps.Dose considerations for anti-cancer drugs in metastatic prostate cancer.Neutropenia as a prognostic factor and safety of second-line therapy with S-1 for advanced or recurrent pancreatic cancer.Effect of leukocyte alteration on treatment outcomes following preoperative chemoradiotherapy in patients with rectal cancer.Prediction of survival by neutropenia according to delivery schedule of oxaliplatin-5-Fluorouracil-leucovorin for metastatic colorectal cancer in a randomized international trial (EORTC 05963).The association between neutropenia and prognosis in stage III colorectal cancer patients receiving adjuvant chemotherapy.Chemotherapy-induced neutropenia and the prognosis of colorectal cancer: a meta-analysis of cohort studies.Beneficial Treatment Management with Trifluridine/Tipiracil in a Patient with Metastatic Colorectal Cancer and Pronounced Hematological Event History during Previous Treatments.Experimental study of antitumour activity and effects on leukocyte count of intraperitoneal administration and hyperthermic intraperitoneal chemoperfusion (HIPEC) with dioxadet in a rat model of ovarian cancer.Evaluation of effectiveness of granulocyte-macrophage colony-stimulating factor therapy to cancer patients after chemotherapy: a meta-analysis.Cytotoxic chemotherapy reduces T cell trafficking to the spleen by downregulating the expression of C-C motif chemokine ligand 21 and C-C motif chemokine ligand 19
P2860
Q26786142-5EA6B985-19A3-4742-963A-487D941C11B4Q28552519-B9D4DDA5-2FE2-4534-9215-E7BBEDBB8AF6Q33733830-511A8483-BE61-40BF-9BF2-78186361480DQ35212672-8181CC08-C742-47CD-94D6-FC507ED21D19Q36160947-C64AB0DA-3644-4DE0-8801-E5F060A69751Q36409909-8F4D7FB6-6739-4C9D-ABD1-BDE82427B046Q36621190-3BCAD7E5-E0D0-4F84-866F-7A7602EFC88EQ37507392-BA3D76DF-7AD7-49DF-906E-C710CC00186FQ38130610-EE294787-49F9-4721-A147-13697BB040A6Q38219193-838E9C43-877B-4BA8-AAEF-BF1BCAD541D2Q39153086-8A55C9AF-C482-4E56-9641-0D56639F7C40Q39231400-826BA7D5-A7DF-48F9-B797-CDC2D8B9C209Q39397948-57DDD15C-FE91-4DE4-8CD5-55A18B50ECF9Q41179372-EDF1EF4A-5956-48F8-931A-4450C010F947Q42380313-78B687C1-F84B-4738-9957-9667B61AA6B3Q43559620-3227DE8F-BE8F-4C55-89BD-A57A9A1AB148Q43631694-FBA95834-EF63-4E93-A499-822818E261DEQ47803255-2FE42644-5764-4086-A1D9-81960162694BQ51743257-2D15B184-C9E7-45F9-BFAA-2CDB31E0F674Q53486371-F3225DE7-E8FD-453E-83BD-45E50841BB60Q55384404-B0FD48ED-8832-499A-8768-BB0613FD2279Q58792079-C804B477-B965-4129-A4B3-7A5940963177
P2860
Meta-analysis of neutropenia or leukopenia as a prognostic factor in patients with malignant disease undergoing chemotherapy.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 20 October 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Meta-analysis of neutropenia o ...... sease undergoing chemotherapy.
@en
Meta-analysis of neutropenia o ...... sease undergoing chemotherapy.
@nl
type
label
Meta-analysis of neutropenia o ...... sease undergoing chemotherapy.
@en
Meta-analysis of neutropenia o ...... sease undergoing chemotherapy.
@nl
prefLabel
Meta-analysis of neutropenia o ...... sease undergoing chemotherapy.
@en
Meta-analysis of neutropenia o ...... sease undergoing chemotherapy.
@nl
P2093
P2860
P1476
Meta-analysis of neutropenia o ...... sease undergoing chemotherapy.
@en
P2093
Ayako Mizota
Chihiro Kondo
Daisuke Takahari
Kohei Shitara
Motoo Nomura
Takashi Ura
Tomoya Yokota
P2860
P2888
P304
P356
10.1007/S00280-010-1487-6
P577
2010-10-20T00:00:00Z